SNTE (Sante Technology Holdings) FCF Margin %: 0.00% (As of . 20)


What is Sante Technology Holdings FCF Margin %?

Sante Technology Holdings SNTE FCF Margin % is 0.00% as of . 20.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sante Technology Holdings's Free Cash Flow for the six months ended in . 20 was $0.00 Mil. Sante Technology Holdings's Revenue for the six months ended in . 20 was $0.00 Mil. Therefore, Sante Technology Holdings's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Sante Technology Holdings's current FCF Yield % is 0.00%.

The historical rank and industry rank for Sante Technology Holdings's FCF Margin % or its related term are showing as below:


SNTE's FCF Margin % is not ranked *
in the Conglomerates industry.
Industry Median: 2.59
* Ranked among companies with meaningful FCF Margin % only.

Sante Technology Holdings FCF Margin % Related Terms

Sante Technology Holdings FCF Margin % Historical Data

* Premium members only.

The historical data trend for Sante Technology Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sante Technology Holdings FCF Margin % Chart

Sante Technology Holdings Annual Data
Trend
FCF Margin %

Sante Technology Holdings Semi-Annual Data
FCF Margin %

SNTE vs TICJ, AXXA, PTEEF: FCF Margin % Comparison

For the Conglomerates subindustry, Sante Technology Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sante Technology Holdings FCF Margin % vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, Sante Technology Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sante Technology Holdings's FCF Margin % falls into.


Sante Technology Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sante Technology Holdings's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

Sante Technology Holdings's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Sante Technology Holdings (SNTE) has a FCF Margin % of 0.00% as of . 20. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sante Technology Holdings and its competitors.
Is Sante Technology Holdings' FCF Margin % too high?
Sante Technology Holdings' current FCF Margin % is 0.00%.
How does Sante Technology Holdings' FCF Margin % compare to TICJ and AXXA?
Sante Technology Holdings' FCF Margin % of 0.00% can be compared against companies in the Conglomerates industry. The industry median FCF Margin % is 2.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Conglomerates company?
The median FCF Margin % among Conglomerates companies is 2.59, based on 551 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sante Technology Holdings and its competitors. For the Conglomerates industry, the median FCF Margin % is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sante Technology Holdings's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sante Technology Holdings stock overvalued right now?
Sante Technology Holdings (SNTE) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sante Technology Holdings (SNTE), the current FCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sante Technology Holdings Business Description

Address 2875 Queens Way, Thousand Oaks, CA, USA, 91362
Sante Technology Holdings Inc. specialises in assisting Asian entrepreneurs and value startups to access the United States capital market through services like RTO and public listings as well as serving as a Company Doctor to clients already listed on OTC and NASDAQ markets. It provides comprehensive services, including Reverse Takeovers (RTOs) and public listings, to Asia-Pacific clients. Its goal is to help, evaluate and enhance internal structure, setup, and publicly accessible information, maximizing shareholder value.